Radiotherapy plus immune checkpoint inhibitor in prostate cancer

The immune checkpoint inhibitor (ICI) is a promising strategy for treating cancer. However, the efficiency of ICI monotherapy is limited, which could be mainly attributed to the tumor microenvironment of the “cold” tumor. Prostate cancer, a type of “cold” cancer, is the most common cancer affecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianjie, Qian, Xinye, Liu, Jinyang, Xue, Feng, Luo, Jing, Yao, Guanqun, Yan, Jun, Liu, Xiaodong, Xiao, Bo, Li, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403272/
https://www.ncbi.nlm.nih.gov/pubmed/37546397
http://dx.doi.org/10.3389/fonc.2023.1210673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403272/
https://www.ncbi.nlm.nih.gov/pubmed/37546397
http://dx.doi.org/10.3389/fonc.2023.1210673

Ejemplares similares